<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <atom:link href="https://feeds.megaphone.fm/the-first-line-of-defense" rel="self" type="application/rss+xml"/>
    <title>The First Line of Defense: Primary Care Clinicians and Early Detection of Pancreatic Cancer </title>
    <link>pancreaticcancerpodcast.com</link>
    <language>en</language>
    <copyright></copyright>
    <description>The First Line of Defense is a 4-part podcast specifically created for primary care clinicians on how they can recognize symptoms and risk factors of pancreatic cancer – including what the future holds for diagnosing patients using ever-developing technology, including AI. Kenner Family Research Fund and Entertainment 2 Affect Change have partnered to share the stories of pancreatic cancer patients, primary care physicians, leading researchers, and specialists in the field.
The goal of this podcast is to educate an informed, but not expert, medical audience on the current state of pancreatic cancer diagnostics, and provide usable tools for clinicians to walk away better equipped to detect a potential pancreatic cancer diagnosis. We want to raise awareness and provide tools for clinicians.

For More Information and Resources:
Visit our website at pancreaticcancerpodcast.com


Meet the People Behind the Microphone:
Jon Hallberg, MD | Sapna Syngal, MD, MPH | Suresh Chari, MD
William Hoos, MBA | Chris Sander, PHD | Steve &amp; Scott Nelson

Learn More About KFRF:
Visit our website at kennerfamilyresearchfund.org


Follow E2AC:

Facebook | Instagram | Twitter | TikTok | LinkedIn</description>
    <image>
      <url>https://megaphone.imgix.net/podcasts/9bddbd22-642f-11ee-872f-63fe3b1eba73/image/The_First_Line_of_Defense_Podcast_Cover_.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress</url>
      <title>The First Line of Defense: Primary Care Clinicians and Early Detection of Pancreatic Cancer </title>
      <link>pancreaticcancerpodcast.com</link>
    </image>
    <itunes:explicit>no</itunes:explicit>
    <itunes:type>serial</itunes:type>
    <itunes:subtitle>Brought to you by the Kenner Family Research Fund</itunes:subtitle>
    <itunes:author>Kenner Family Research Fund</itunes:author>
    <itunes:summary>The First Line of Defense is a 4-part podcast specifically created for primary care clinicians on how they can recognize symptoms and risk factors of pancreatic cancer – including what the future holds for diagnosing patients using ever-developing technology, including AI. Kenner Family Research Fund and Entertainment 2 Affect Change have partnered to share the stories of pancreatic cancer patients, primary care physicians, leading researchers, and specialists in the field.
The goal of this podcast is to educate an informed, but not expert, medical audience on the current state of pancreatic cancer diagnostics, and provide usable tools for clinicians to walk away better equipped to detect a potential pancreatic cancer diagnosis. We want to raise awareness and provide tools for clinicians.

For More Information and Resources:
Visit our website at pancreaticcancerpodcast.com


Meet the People Behind the Microphone:
Jon Hallberg, MD | Sapna Syngal, MD, MPH | Suresh Chari, MD
William Hoos, MBA | Chris Sander, PHD | Steve &amp; Scott Nelson

Learn More About KFRF:
Visit our website at kennerfamilyresearchfund.org


Follow E2AC:

Facebook | Instagram | Twitter | TikTok | LinkedIn</itunes:summary>
    <content:encoded>
      <![CDATA[<p><em>The First Line of Defense</em> is a 4-part podcast specifically created for primary care clinicians on how they can recognize symptoms and risk factors of pancreatic cancer – including what the future holds for diagnosing patients using ever-developing technology, including AI. <a href="https://www.kennerfamilyresearchfund.org/">Kenner Family Research Fund</a> and <a href="https://e2ac.org/">Entertainment 2 Affect Change</a> have partnered to share the stories of pancreatic cancer patients, primary care physicians, leading researchers, and specialists in the field.</p><p>The goal of this podcast is to educate an informed, but not expert, medical audience on the current state of pancreatic cancer diagnostics, and provide usable tools for clinicians to walk away better equipped to detect a potential pancreatic cancer diagnosis. We want to raise awareness and provide tools for clinicians.</p><p><br></p><h3>For More Information and Resources:</h3><h3>Visit our website at <a href="www.pancreaticcancerpodcast.com"><em>pancreaticcancerpodcast.com</em></a>
</h3><h3><br></h3><h3>Meet the People Behind the Microphone:</h3><h3>Jon Hallberg, MD | Sapna Syngal, MD, MPH | Suresh Chari, MD</h3><h3>William Hoos, MBA | Chris Sander, PHD | Steve &amp; Scott Nelson</h3><h3><br></h3><h3>Learn More About KFRF:</h3><h3>Visit our website at <a href="https://www.kennerfamilyresearchfund.org/"><em>kennerfamilyresearchfund.org</em></a>
</h3><h3><br></h3><h3>Follow E2AC:</h3><h3>
<a href="https://www.facebook.com/E2ACorg/">Facebook</a> | <a href="https://www.instagram.com/e2acorg">Instagram</a> | <a href="https://twitter.com/e2acorg">Twitter</a> | <a href="https://www.tiktok.com/@e2acorg">TikTok</a> | <a href="https://www.linkedin.com/company/entertainment-2-affect-change/">LinkedIn</a>
</h3>]]>
    </content:encoded>
    <itunes:owner>
      <itunes:name></itunes:name>
      <itunes:email>redins@e2ac.org</itunes:email>
    </itunes:owner>
    <itunes:image href="https://megaphone.imgix.net/podcasts/9bddbd22-642f-11ee-872f-63fe3b1eba73/image/The_First_Line_of_Defense_Podcast_Cover_.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <item>
      <title>Ep1: From Knowledge to Action: Early Detection of Pancreatic Cancer in Primary Care</title>
      <link>https://www.pancreaticcancerpodcast.com/podcast-series/v/ep1</link>
      <description>In the first episode of the The First Line of Defense podcast, we discuss early detection of pancreatic cancer in primary care. While the initial presentation of pancreatic cancer can be vague and non-specific, if you’re suspicious, Primary Care Clinicians should consider imaging, such as an abdominal and pelvic CT scan for further evaluation.</description>
      <pubDate>Sun, 29 Oct 2023 23:03:18 -0000</pubDate>
      <itunes:title>From Knowledge to Action: Early Detection of Pancreatic Cancer in Primary Care</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>1</itunes:episode>
      <itunes:author>Kenner Family Research Fund</itunes:author>
      <itunes:subtitle>The goal of this podcast is to educate a medical audience on the current state of pancreatic cancer diagnostics.</itunes:subtitle>
      <itunes:summary>In the first episode of the The First Line of Defense podcast, we discuss early detection of pancreatic cancer in primary care. While the initial presentation of pancreatic cancer can be vague and non-specific, if you’re suspicious, Primary Care Clinicians should consider imaging, such as an abdominal and pelvic CT scan for further evaluation.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In the first episode of the<em> The First Line of Defense</em> podcast, we discuss early detection of pancreatic cancer in primary care. While the initial presentation of pancreatic cancer can be vague and non-specific, if you’re suspicious, Primary Care Clinicians should consider imaging, such as an abdominal and pelvic CT scan for further evaluation.</p>]]>
      </content:encoded>
      <itunes:duration>1071</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[6e4d28b0-76af-11ee-849b-a31513829741]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT5398425504.mp3?updated=1698620934" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Ep2: Genetic Insights: Understanding Pancreatic Cancer Risk in Primary Care</title>
      <link>https://www.pancreaticcancerpodcast.com/podcast-series/v/ep2</link>
      <description>In the second episode of the The First Line of Defense podcast, we discuss genetic insights and understanding pancreatic cancer risk in primary care. While there are many considerations a Primary Care Clinician has to make when diagnosing pancreatic cancer, family histories are an important piece of this complex puzzle.</description>
      <pubDate>Sun, 29 Oct 2023 23:00:28 -0000</pubDate>
      <itunes:title>Genetic Insights: Understanding Pancreatic Cancer Risk in Primary Care</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>2</itunes:episode>
      <itunes:author>Kenner Family Research Fund</itunes:author>
      <itunes:subtitle>In this episode we'll explore the role genetic testing plays in screening and risk awareness.</itunes:subtitle>
      <itunes:summary>In the second episode of the The First Line of Defense podcast, we discuss genetic insights and understanding pancreatic cancer risk in primary care. While there are many considerations a Primary Care Clinician has to make when diagnosing pancreatic cancer, family histories are an important piece of this complex puzzle.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In the second episode of the<em> The First Line of Defense</em> podcast, we discuss genetic insights and understanding pancreatic cancer risk in primary care. While there are many considerations a Primary Care Clinician has to make when diagnosing pancreatic cancer, family histories are an important piece of this complex puzzle.</p>]]>
      </content:encoded>
      <itunes:duration>840</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[08b27776-76af-11ee-a9e6-178d0218a3d8]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT5813913993.mp3?updated=1698620764" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Ep3: From Data to Diagnosis: Transforming Early Detection of Pancreatic Cancer</title>
      <link>https://www.pancreaticcancerpodcast.com/podcast-series/v/ep3</link>
      <description>Primary Care Clinicians have an important role to play, and it’s not easy. There is hope for the future of early detection with biomarkers and A-I. Not only is early detection increasingly more feasible, it makes a significant difference in survival.</description>
      <pubDate>Sun, 29 Oct 2023 22:57:00 -0000</pubDate>
      <itunes:title>From Data to Diagnosis: Transforming Early Detection of Pancreatic Cancer</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>3</itunes:episode>
      <itunes:author>Kenner Family Research Fund</itunes:author>
      <itunes:subtitle>We explore immediate next steps for clinicians who suspect a patient has pancreatic cancer, the future of diagnosis, biomarkers, AI scans, and vaccines.</itunes:subtitle>
      <itunes:summary>Primary Care Clinicians have an important role to play, and it’s not easy. There is hope for the future of early detection with biomarkers and A-I. Not only is early detection increasingly more feasible, it makes a significant difference in survival.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Primary Care Clinicians have an important role to play, and it’s not easy. There is hope for the future of early detection with biomarkers and A-I. Not only is early detection increasingly more feasible, it makes a significant difference in survival.</p>]]>
      </content:encoded>
      <itunes:duration>1252</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[92a83836-76ae-11ee-a5d0-478935ef102a]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT5686576056.mp3?updated=1698774544" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Ep4: A Conversation with Chris Sander on AI and the Prediction of Pancreatic Cancer (Bonus Episode)</title>
      <link>https://www.pancreaticcancerpodcast.com/podcast-series/v/bonus-ep</link>
      <description>In this special bonus episode of The First Line of Defense podcast, Chris Sander, a computational biologist based at the Dana-Farber Cancer Center and Harvard Medical School, explains how his research on A-I and machine learning are being used to help with early cancer detection. Even with the multiple challenges inherent in AI, this study represents a much needed and valuable step in earlier cancer detection efforts.</description>
      <pubDate>Sun, 29 Oct 2023 22:52:00 -0000</pubDate>
      <itunes:title>A Conversation with Chris Sander on AI and the Prediction of Pancreatic Cancer</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>4</itunes:episode>
      <itunes:author>Kenner Family Research Fund</itunes:author>
      <itunes:subtitle>Listen to a conversation with Chris Sander as he explains his research on how A-I and machine learning are being used to help with early cancer detection.</itunes:subtitle>
      <itunes:summary>In this special bonus episode of The First Line of Defense podcast, Chris Sander, a computational biologist based at the Dana-Farber Cancer Center and Harvard Medical School, explains how his research on A-I and machine learning are being used to help with early cancer detection. Even with the multiple challenges inherent in AI, this study represents a much needed and valuable step in earlier cancer detection efforts.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this special bonus episode of <em>The First Line of Defense</em> podcast, Chris Sander, a computational biologist based at the Dana-Farber Cancer Center and Harvard Medical School, explains how his research on A-I and machine learning are being used to help with early cancer detection. Even with the multiple challenges inherent in AI, this study represents a much needed and valuable step in earlier cancer detection efforts.</p>]]>
      </content:encoded>
      <itunes:duration>2197</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[dfcbbf1c-76ad-11ee-b6ae-9bd986ca23c9]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT8669400881.mp3?updated=1698675423" length="0" type="audio/mpeg"/>
    </item>
  </channel>
</rss>
